Select Publications
Conference Presentations
2014, 'Effect and mechanism of PF299804 alone and in combination with STAT3 inhibitor in human sarcoma cell lines', presented at 105th Annual Meeting of the American-Association-for-Cancer-Research (AACR), CA, San Diego, 05 April 2014 - 09 April 2014, http://dx.doi.org/10.1158/1538-7445.AM2014-1723
,2009, 'Investigation of IGF-IR pathways in an orthotopic mouse model of human osteosarcoma with spontaneous pulmonary metastasis.', presented at IX International meeting on Cancer Induced Bone Disease., Arlington, VA USA, 28 October 2009 - 31 October 2009
,Conference Abstracts
2019, 'Synergistic effect of targeting both CDK4/6 and mTORin sarcoma cell lines', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 79, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), GA, Atlanta, 29 March 2019 - 03 April 2019, http://dx.doi.org/10.1158/1538-7445.AM2019-3907
,2016, 'Anti-tumor effect and mechanisms of concurrent targeting EGFR and metabolism in sarcoma cell lines', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, GERMANY, Munich, Vol. 69, pp. S37 - S38, presented at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, GERMANY, Munich, 29 November 2016 - 02 December 2016, http://dx.doi.org/10.1016/S0959-8049(16)32693-4
,2015, 'Synergistic effects of concurrent inhibition of EGFR and STAT3 in soft tissue sarcoma cell lines', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, AUSTRIA, Vienna, Vol. 51, pp. S704 - S705, presented at European Cancer Congress, AUSTRIA, Vienna, http://dx.doi.org/10.1016/S0959-8049(16)31921-9
,